Biocon Limited Q4 & FY23 Earnings Conference Call Transcript

Transcript - Biocon Limited Q4FY23 Earnings Call Page 5 of 29 Biocon shareholding in both Biocon Biologics and Syngene in the consolidated results. Now coming to full-year numbers …

CouponFollow Extension

34%
OFF

Transcript Biocon Limited Q4 FY19 Earnings Conference Call …

2 weeks from now

Transcript - Biocon Limited Q4 FY19 Earnings Call Page 3 of 13 Core margins, that is EBITDA margins net of licensing, impact of FOREX and R&D, stood at 34%, which is up from last …

biocon.com

FAQs about Biocon Limited Q4 & FY23 Earnings Conference Call Transcript Coupon?

Will Biocon's Q3 FY23 earnings conference call be 'listen-only'?

I am Saurabh Paliwal from the Biocon Investor Relations team, and I would like to welcome you to Biocon's Q3 FY23 Earnings conference call. I would like to indicate that all participants will be in the ‘listen-only’ mode and there will be an opportunity for you to ask questions once the management’s commentary concludes. ...

Will Biocon's Q2 earnings call be listen-only?

Good evening, everyone. I'm Saurabh Paliwal from Biocon Investor Relations team, and I would like to welcome you to Biocon's Earnings call for Q2 FY '24. I would like to indicate that all the participants will be in a listen-only mode, and there'll be an opportunity to ask questions after the opening remarks conclude. ...

How much revenue did Biocon biologics generate in fy24?

Good morning and thanks for the opportunity. You previously guided for US$ 1.8 bn revenue for Biocon Biologics in FY24 and the US$ 500 million EBITDA. So, are transaction with Serum? ...

Will Biocon biologics Cross 2000 crores in Q4?

But, let me start by saying that you have already seen that we are at a ₹1500 crores level this quarter for Biocon Biologics and we expect this number when we capture the full financials of the Viatris business in Q4, to cross ₹2000 crores. Cyndrella, morning. ...

Who is the new head of Regulatory Affairs at Biocon Limited?

Dr. Arlene Wolny joins as Global Head of Regulatory Affairs and Mr. Ramprasad Bhat joins as Head of Branded Formulations in India. At Biocon Limited, Mr. Nitin Tiwari has been appointed as the Head of Quality for the Generic business. Let me now expand on Kiran's opening view on the performance for the quarter. ...

Who is the CEO of Biocon Limited?

Today, to discuss the Company's Business Performance and Outlook, we have Dr. Kiran Mazumdar Shaw, our Executive Chairperson, Mr. Siddharth Mittal, CEO and Managing Director of Biocon Limited, along with other senior management personnel from business segments including Generics, Biosimilars and Research Services. ...